Germany
Japan
United Kingdom
China
Antibodies
View as table Download
Rabbit Polyclonal PD-L1 Antibody
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | PD-L1 antibody was raised against a 17 amino acid synthetic peptide from near the center of human PD-L1. The immunogen is located within amino acids 60 - 110 of PD-L1. |
Rabbit Polyclonal Nephrin Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Nephrin antibody was raised against a 14 amino acid synthetic peptide from near the carboxy terminus of human Nephrin. The immunogen is located within the last 50 amino acids of Nephrin. |
Rabbit Polyclonal STIM1 Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | STIM1 antibody was raised against a 24 amino acid synthetic peptide from near the carboxy terminus of human STIM1. The immunogen is located within the last 50 amino acids of STIM1. |
Rabbit Polyclonal Anti-MFN2 Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | MFN2 antibody was raised against a 17 amino acid peptide near the center of human MFN2. The immunogen is located within amino acids 250 - 300 of MFN2. |
Rabbit Polyclonal TACE Antibody
| Applications | IF, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | TACE antibody was raised against a peptide corresponding to amino acids near the carboxy terminus of human TACE This sequence differs from those of mouse and rat TACE by one amino acid. |
Rabbit Polyclonal Anti-TXNIP Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | TXNIP antibody was raised against a 16 amino acid peptide near the center of human TXNIP. The immunogen is located within amino acids 110 - 160 of TXNIP. |
Rabbit Polyclonal Anti-ADORA2B Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | ADORA2B antibody was raised against a 19 amino acid peptide near the carboxy terminus of human ADORA2B. The immunogen is located within the last 50 amino acids of ADORA2B. |
Rabbit Polyclonal S1P1 Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | S1P1 antibody was raised against a 14 amino acid synthetic peptide near the carboxy terminus of the human S1P1. The immunogen is located within the last 50 amino acids of S1P1. |
Goat Polyclonal Anti-BDNF Antibody
| Applications | IF, IHC |
| Reactivities | Human, Mouse, Rat (Expected from sequence similarity: Dog) |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for Anti-BDNF Antibody: Peptide with sequence ETKCNPMGYTKE, from the internal region of the protein sequence according to NP_001700.2; NP_001700.2; NP_733928.1; NP_733929.1; NP_733930.1; NP_733931.1. |
Rabbit polyclonal Syndecan4 (Ab-179) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human Syndecan4 around the phosphorylation site of serine 179 (E-G-SP-Y-D). |
Active filters
Category
-
Antibodies
- Primary Antibodies
Reactivities
- Rat
Applications
- IF
Isotypes
- IgG
Families
- Transmembrane
Filter by
Target Symbol
- APP (5)
- CANX (5)
- GJA1 (5)
- BAX (4)
- ANTXR1 (2)
- ATP7B (2)
- BCL2L13 (2)
- CADM3 (2)
- CD248 (2)
- CD63 (2)
- CERS5 (2)
- CNGA2 (2)
- DRAM1 (2)
- EDNRA (2)
- ERN1 (2)
- FZD4 (2)
- FZD5 (2)
- GALNT10 (2)
- GRIK4 (2)
- HTR4 (2)
- ITGA4 (2)
- JPH3 (2)
- LAMP1 (2)
- MAVS (2)
- MET (2)
- NCSTN (2)
- NPHS1 (2)
- OPRM1 (2)
- PLXDC1 (2)
- PLXDC2 (2)
- PSENEN (2)
- PTGDR2 (2)
- RTN4 (2)
- SLC9A1 (2)
- SLITRK1 (2)
- SLITRK2 (2)
- SLITRK4 (2)
- SLITRK5 (2)
- SLITRK6 (2)
- STEAP3 (2)
- TNFRSF10C (2)
- TOMM70 (2)
- TRPC3 (2)
- WNT10A (2)
- ACKR3 (1)
- ACSL1 (1)
- ACVR1B (1)
- ACVR1C (1)
- ACVRL1 (1)
- ADAM17 (1)
- ADAM29 (1)
- ADCY6 (1)
- ADCY8 (1)
- ADGRA2 (1)
- ADGRF5 (1)
- ADGRL1 (1)
- ADGRL2 (1)
- ADORA2B (1)
- ADORA3 (1)
- ADRA1B (1)
- ADRA2A (1)
- ADRB2 (1)
- AGTR1 (1)
- AIFM1 (1)
- AIG1 (1)
- AMIGO1 (1)
- ANG (1)
- AQP2 (1)
- ARMCX2 (1)
- ARMCX3 (1)
- ATG9A (1)
- ATG9B (1)
- ATP11A (1)
- ATP5MC3 (1)
- ATP6AP2 (1)
- BAMBI (1)
- BCAP29 (1)
- BCL2 (1)
- BCL2L1 (1)
- BCL2L2 (1)
- BDNF (1)
- BFAR (1)
- BLCAP (1)
- BMPR1B (1)
- C1QTNF1 (1)
- C1QTNF6 (1)
- CABP7 (1)
- CACNA1H (1)
- CADM4 (1)
- CALHM1 (1)
- CAMP (1)
- CASR (1)
- CAV2 (1)
- CCR3 (1)
- CD244 (1)
- CD274 (1)
- CD276 (1)
- CD81 (1)
- CD82 (1)
- CDH2 (1)
Antibody Hosts
Clonalities
Conjugates
Modifications
Pathways
- Neuroactive ligand-receptor interaction (48)
- Cytokine-cytokine receptor interaction (29)
- Pathways in cancer (26)
- Calcium signaling pathway (21)
- Alzheimer's disease (19)
- Colorectal cancer (18)
- Cell adhesion molecules (CAMs) (13)
- Metabolic pathways (13)
- Endocytosis (12)
- Apoptosis (11)
- Gap junction (11)
- Melanogenesis (11)
- Amyotrophic lateral sclerosis (ALS) (10)
- Focal adhesion (10)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (9)
- Huntington's disease (9)
- MAPK signaling pathway (9)
- Neurotrophin signaling pathway (9)
- Regulation of actin cytoskeleton (9)
- Wnt signaling pathway (9)
- Basal cell carcinoma (8)
- Leukocyte transendothelial migration (8)
- p53 signaling pathway (8)
- Natural killer cell mediated cytotoxicity (7)
- Notch signaling pathway (7)
- Vascular smooth muscle contraction (7)
- Adherens junction (6)
- Axon guidance (6)
- Dilated cardiomyopathy (6)
- Adipocytokine signaling pathway (5)
- Antigen processing and presentation (5)
- Chemokine signaling pathway (5)
- Hematopoietic cell lineage (5)
- Lysosome (5)
- Melanoma (5)
- TGF-beta signaling pathway (5)
- Cardiac muscle contraction (4)
- ECM-receptor interaction (4)
- Epithelial cell signaling in Helicobacter pylori infection (4)
- Hypertrophic cardiomyopathy (HCM) (4)
- Jak-STAT signaling pathway (4)
- Long-term depression (4)
- Pancreatic cancer (4)
- Parkinson's disease (4)
- Prion diseases (4)
- Prostate cancer (4)
- Chronic myeloid leukemia (3)
- Cytosolic DNA-sensing pathway (3)
- ErbB signaling pathway (3)
- Glioma (3)
- GnRH signaling pathway (3)
- Hedgehog signaling pathway (3)
- Long-term potentiation (3)
- O-Glycan biosynthesis (3)
- Oocyte meiosis (3)
- Oxidative phosphorylation (3)
- Progesterone-mediated oocyte maturation (3)
- Purine metabolism (3)
- RIG-I-like receptor signaling pathway (3)
- Renal cell carcinoma (3)
- Toll-like receptor signaling pathway (3)
- Vibrio cholerae infection (3)
- B cell receptor signaling pathway (2)
- Bladder cancer (2)
- Heparan sulfate biosynthesis (2)
- Renin-angiotensin system (2)
- SNARE interactions in vesicular transport (2)
- Small cell lung cancer (2)
- Taste transduction (2)
- Tight junction (2)
- ABC transporters (1)
- Allograft rejection (1)
- Arachidonic acid metabolism (1)
- Asthma (1)
- Biosynthesis of unsaturated fatty acids (1)
- Dorso-ventral axis formation (1)
- Drug metabolism - cytochrome P450 (1)
- Endometrial cancer (1)
- Fatty acid metabolism (1)
- Fc epsilon RI signaling pathway (1)
- Glutathione metabolism (1)
- Glycosphingolipid biosynthesis - lacto and neolacto series (1)
- Graft-versus-host disease (1)
- Linoleic acid metabolism (1)
- Metabolism of xenobiotics by cytochrome P450 (1)
- N-Glycan biosynthesis (1)
- NOD-like receptor signaling pathway (1)
- Non-small cell lung cancer (1)
- PPAR signaling pathway (1)
- Pathogenic Escherichia coli infection (1)
- Pyrimidine metabolism (1)
- Retinol metabolism (1)
- Systemic lupus erythematosus (1)
- T cell receptor signaling pathway (1)
- Thyroid cancer (1)
- Type I diabetes mellitus (1)
- Type II diabetes mellitus (1)
- Viral myocarditis (1)